News
Vasculitis in the News
An RSS (Really Simple Syndication) feed is a news aggregator that uses software to search the internet for content that contains specific keywords.This RSS feed contains articles related to all forms of vasculitis. The articles in this feed come from a variety of online sources and are not directly associated with the Vasculitis Foundation (VF). Inclusion of an article in this RSS feed does not imply endorsement of the content by the VF.
- Leukocytoclastic Vasculitis Market to Reach US$206.2 Million at 3.5% CAGR by 2033 | Persistence Market Research - openPR.com
- The week in pharma: action reaction and insight – week to November 6, 2026 - The Pharma Letter
- Severe Infection Risk Peaks Early in Biopsy-Proven Giant Cell Arteritis - Bioengineer.org
- Two Rare Brain Vessel Inflammations Look Alike but Differ in Biology, Diagnosis, and Outcome - Bioengineer.org
- #fyp #foryou #reels #firstvideochallenge - NewsBreak: Local News & Alerts
- Making the argument (again) that we should scrap ‘lived experience’ - ANCA Vasculitis News
- Psoas and Pararenal Abscess Caused by Nocardia cyriacigeorgica During Combined Immunosuppression for Immunoglobulin G4-Related Large- and Medium-Vessel Vasculitis - Cureus
- Trust Your Gut: One Woman’s Rare Disease Journey - The Daily Tribune News
- Cavitary Pneumocystis Pneumonia in Advanced HIV Mimicked Vasculitis on ANCA Testing - Bioengineer.org
- InflaRx to Launch Two Phase 2 Izicopan Trials for ANCA-Associated Vasculitis in 2027 - Kalkine Media
- Developer intends to launch 2 trials next year to test oral vasculitis treatment - ANCA Vasculitis News
- One of two planned InflaRx (IFRX) trials will test replacing steroid treatment. - Stock Titan
- InflaRx N.V. - Common Stock (IFRX) Stock Price, News, Quote & History - FinancialContent
- InflaRx Targets Kidney Protection, Steroid Reduction in AAV With Izicopan Trials - TradingView
- InflaRx (IFRX) Launches Phase 2 Trials for Izicopan Targeting AN - GuruFocus
In Partnership With
ANCA Vasculitis News, a Bionews site, provides clear, reliable news, research updates, and real-world perspectives to help people living with ANCA vasculitis and their caregivers feel more informed, confident, and supported throughout their care journey. Information is not meant to replace medical advice.